Indication
Treatment of bleeding episodes and for the prevention of bleeding.
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
Hemophilia A;Hemophilia B;Factor VII Deficiency
Marketing Authorisation Holder: UGA Biopharma
INN: eptacog alfa (activated)
AI Drug & Interaction Analysis
Free account required
Ask Osler about HemAryo: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.